Risultati per: La qualità dei nutraceutici e position paper per l’appropriato uso in medicina generale

Rapporto Agenas-Aiop, qualità cure eccellente nel 27% di strutture private

Obiettivo mettere in relazione medicina olistica e tradizionale

Il docente oggi a presentazione del rapporto Registro tumori Fvg

La scoperta ha aperto la via ai vaccini anti Covid-19

Si è scelto di assegnare il premio ai «genitor» della terapia a mRna, più di 15 anni dopo la loro visionaria collaborazione in laboratorio

La scoperta ha aperto la via ai vaccini anti Covid-19

Annals of Internal Medicine, Ahead of Print.

Annals of Internal Medicine, Ahead of Print.

Introduction
Patient-reported outcomes (PRO) are currently collected from trial participants using paper questionnaires by the Clinical Trials and Statistics Unit at The Institute of Cancer Research (ICR-CTSU). Streamlining PRO collection using electronic questionnaires (ePRO) may improve data collection and patient experience. Here, we outline our protocol for a Study within a trial of electronic versus paper-based Patient-Reported oUtcomes CollEction (SPRUCE), which investigates the acceptability of ePRO in oncology clinical trials.

Methods and analysis
SPRUCE was developed alongside patient and public contributors. SPRUCE runs in multiple host trials with a partially randomised patient preference design, allowing participants to be randomised or choose their preference of electronic or paper questionnaires. Questionnaires are scheduled in accordance with host trial follow-up. The primary objective will assess differences in return rates (compliance) between ePRO and paper PROs at the first timepoint post-host trial intervention in the randomised group. Paper PRO compliance is expected to be 90%. 244 randomised participants are required to exclude ≤80% compliance rates with ePRO (10% non-inferiority margin, with 80% power and one-sided alpha=0.05). SPRUCE aims to assess acceptability of ePRO in oncology clinical trials, establish whether ePRO is acceptable to ICR-CTSU trial participants and can capture complete PRO data, consistent with paper PROs.

Ethics and dissemination
The SPRUCE protocol (ICR-CTSU/2021/10074) was approved by the Coventry and Warwick Central Research Ethics Committee (21/WM/0223) on 21 October 2021. Results will be disseminated via presentations, publications and lay summaries. No participant identifiable data will be included.

Trial registration
SWAT169.

Comunicato del 19/09/2023 n°52

Ordine dei medici, progetto per l’orientamento in 300 istituti

Il punto a Firenze con Fondazione Menarini e Nasa

Comunicato del 12/09/2023 n°51

‘Innovare per potenziare e migliorare il nostro lavoro’